A revolution in the treatment and rehabilitation of muscle/tendon injuries is on its way with the development of a ground-breaking new intelligent technology developed at Griffith University and the University of Auckland.
Called iTraining, the biomedically engineered system works in real time to provide feedback on the stresses and strains that affect a specific muscle or tendon, either following injury or in the prevention of injury.
Following the award of a grant of nearly $1m from Australian Research Council and industry partners, Professor David Lloyd, from Griffith’s Menzies Health Institute Queensland, and other colleagues are now preparing to undertake a large three-part study that will focus on the Achilles tendon.
“Currently the mechanical environment of the Achilles tendon is poorly understood because of difficulties associated with directly measuring the stresses and strains experienced throughout the tendon in daily activities. If these issues can be overcome, it will be possible to identify the loading conditions required to facilitate favourable structural and mechanical adaption of healthy, as well as injured or diseased Achilles tendons,” says Professor Lloyd.
Potential to radically transform
“The technology to achieve this goal is now within reach and has the potential to radically transform the way athletic training and rehabilitation programs for the Achilles tendon are designed and monitored.
“The approach will allow the trainer to identify an individual’s optimal loading conditions for positive structural and mechanical adaption of their Achilles tendon, by using methods that integrate the necessary technologies to measure stress-strain of the tendon in real time.”
The study will be broken into three parts. Part A will aim to determine the optimal loading conditions required to alter the structural, mechanical and biochemical properties of the Achilles tendon; Part B will be to develop the iTraining system which will entail participants wearing next generation wearable sensors coupled with computer models, to provide real-time biofeedback of the tendon’s mechanical behaviour; Part C will determine the efficacy of an iTraining program to alter the structural properties of the human Achilles tendon.
Professor Lloyd says the iTraining approach will be likely to have broad application to other tendons and musculoskeletal tissues within the body.
“This new ‘intelligent’ approach to training and rehabilitation is at the forefront of modern developments in biomechanics, rehabilitation engineering, sports science and sports medicine.
“iTraining has the potential to radically transform the practice of exercise prescription across the full spectrum from elite performance to rehabilitation of acute and chronic musculoskeletal conditions,” he says.
“A key feature of this approach is that feedback is subject specific and therefore consistent with the concept of the ‘quantitative’ self and the trend in science and practice is of course, to move towards models of personalised medicine and rehabilitation.”
Professor Lloyd says he envisages that the technology could be available in public gyms and physiotherapy practices in as little as four years.
The Latest on: Personalised medicine
via Google News
The Latest on: Personalised medicine
- Could personalized laws help create a more equal society? A new book explores possibilitieson October 22, 2021 at 5:00 am
From speed limits to consumer protections, UChicago legal scholar Omri Ben-Shahar and Tel Aviv University's Ariel Porat rethink the legal system in their new book.
- Precision Medicine Market to reach US$ 114,891 Mn by end of 2028, Says Coherent Market Insightson October 21, 2021 at 9:45 am
Precision medicine sometimes referred to as "holistic medicine" is a highly specialized way to tailor personalized medicine to specific individuals, taking into consideration differences in genetics, ...
- Personalized clotting profiles could benefit people at risk from strokes and heart attackson October 20, 2021 at 7:28 pm
People at risk from strokes and heart attacks could benefit from personalized clotting profiles to help clinicians prescribe more precise treatments, thanks to new research.
- Personalized Medicine Market May See Big Move | GE Healthcare, Amgen, Abbotton October 20, 2021 at 4:47 pm
The“ Personalized Medicine – Market Development Scenario ” Study has been added to HTF MI database. The study covers in-depth ...
- Pandemic innovations offer potential to drive advances in personalized medicineon October 20, 2021 at 12:02 am
New article discusses how COVID-19 biopharmaceutical innovations could drive advances in personalized medicineWatson-Marlow Fluid Technology Group shares insights from the Personalized Medicine ...
- Medacta extends the personalized medicine concept to total knee revision surgeries with the unique and innovative MyKnee R patient-specific solutionon October 19, 2021 at 6:00 am
Product Launch19.10.2021 / 19:00 Media release Medacta extends the personalized medicine concept to total knee revision surgeries with the unique and innovative MyKnee R patient-specific ...
- Is Personalized Medicine Finally Gaining Traction in Europe?on October 18, 2021 at 5:50 am
This column has commented previously—and occasionally scathingly—about the gap between words and action on personalized medicine in Europe, but a new straw has appeared in the wind that may mean ...
- Bracco Celebrates Personalized and Precision Medicine Innovations at RSNA 2021on October 18, 2021 at 5:27 am
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, today announces diagnostic imaging, contrast media and informatics ...
- Personalized medicine: Platform enables comparative research on cancerous tumorson October 12, 2021 at 7:07 am
Researchers have developed an algorithm that enhances the ability to compare tumors between different patients, overcoming high inter-patient variability.
- Biognosys Supports Cancer Scout, a Large-Scale Multi-Omics Research Project to Accelerate Personalized Cancer Medicineon October 11, 2021 at 11:02 pm
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today that it is supporting Cancer Scout as Proteomics provider. Cancer Scout is a large-scale ...
via Bing News